Journal list menu
Author Guidelines
Sections
1. Submission
2. Aims and Scope
3. Preparing your Submission
4. Editorial Policies and Ethical Considerations
5. Author Licensing
6. Publication Process After Acceptance
7. Post Publication
8. Editorial Office Contact Details
Thank you for your interest in Plant Biotechnology Journal (PBJ). Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.
Format Free Submission
PBJ has removed all formatting requirements for the initial submission of articles to the journal. Under this scheme new manuscripts, or manuscripts previously considered by other journals, can be submitted to PBJ without excessive formatting/reformatting requirements. As long as manuscripts contain a title, author list, abstract, introduction, results/discussion, methods, and bibliography, we will be happy to process the submission through our normal procedures, irrespective of exactly how it is formatted. The aim is to allow swift consideration of the work, with only those manuscripts that have to be resubmitted following review, or which directly go on to be provisionally accepted for publication, needing to be reformatted to PBJ style. The review process itself will proceed in exactly the same way as in previous years.
Once you have prepared your submission, or resubmission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/plantbiotechjournal. For intial submission, the paper can be submitted as a single pdf or as individual manuscript and figure files. Revised manuscripts should be in their final correctly formatted form (following the guidelines below) when submitted, using red font to indicate the revised sections of the manuscript.
The submission system will prompt you to use an ORCID iD (a unique author identifier) to help distinguish your work from that of other researchers – its use is mandatory. Click here to find out more.
Click here for more details on how to use ScholarOne
For help with submissions, please contact: plant-biotechj@wiley.com
We look forward to your submission.
Plant Biotechnology Journal aims to publish high-impact original research and incisive reviews by leading researchers in applied plant science, with an emphasis on molecular plant sciences and their applications through plant biotechnology. We aim to provide a forum for the most important advances in this field, including curiosity-driven studies with the potential for application, strategic research in plant biotechnology, scientific analysis of key issues for the beneficial application of plant sciences and scientific analysis of the performance of the products of plant biotechnology in practice.
Plant Biotechnology Journal publishes four categories of papers:
Research Articles
To be accepted for publication in Plant Biotechnology Journal, original research papers will need to present major new findings with conclusions thoroughly supported by critical experimental evidence and make a substantial contribution to plant biotechnology and/or scientific understanding.
Review Articles
Reviews must accordingly provide a high level of insight and synthesis beyond a summary of published work. Sciences underpinning plant biotechnology include functional genomics and proteomics, molecular genetics, physiology, biochemistry and cell biology, with applications through molecular marker, mutant and transgenic approaches. Applications may involve agriculture, horticulture, forestry, biodiversity and conservation, enhanced yield, reduced environmental impact, phytoremediation, environmental sensors, improved foods and food-processing, biofuels and biomaterials including pharmaceuticals from terrestrial, aquatic or marine plant systems including industrial crops and natural systems.
Brief Communications
Brief Communications should be no more than 1500 words including the figure/table legend, should not have an abstract, and should contain no more than one illustration/table and a maximum of 10 references. The final article should take up no more than 3 printed pages. Supplementary material should not be included for this article type. Guidelines for presentation are as for Research articles above.
Special Issue articles
PBJ aims to publish special issues, typically comprising specially commissioned review papers on an emerging topic identified by the Editorial Board.
Cover letters
Cover letters are mandatory and should be supplied on submission. Cover letters should specifically describe the novelty of the paper and the broad appeal to the readership.
Word limit
PBJ requires that Research Articles are no longer than 7000 words with no more than 7 Figures and Tables in total. Review Articles should be no more than 9000 words, with a total of no more than 15 Figures and Tables.
To support this process all manuscripts must have a word count immediately following the covering page listing the authors and their affiliations. The word count must include all sections including table legends, however, figure legends, references and supplementary/supporting data should not be included in the word count. Research articles containing more than 7000 words and reviews containing more than 9000 words may be returned to the authors without review. Brief Communications containing more than 1500 words and more than one illustration will also be returned to the authors without review.
The following sections must be included as part of the word count: summary; introduction; results; discussion; experimental procedures; acknowledgements and table titles. The following sections are excluded from the word count: title page, including author list and author affiliations; running head; any words that form part of a table or figure; references; and supporting information.
Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures; supporting information files (optional) as required.
Text file
The text file should be presented in the following order: (i) Summary, not exceeding 250 words; (ii) Introduction; (iii) Results; (iv) Discussion; (v) Experimental procedures; (vi) Accession numbers; (vii) Acknowledgements; (viii) Short legends for Supporting Information; (ix) References; (x) Tables; (xi) Figure legends; (xii) Figures. The Results and Discussion sections may be combined and may contain subheadings. Figures and Supporting Information should be supplied as separate files, and not incorporated into the main manuscript text file. Authors should also refer to the Editorial Policies section below before preparing their manuscript.
Title
The title should be a short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips).
Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing. A separate subsection entitled ‘Author Contributions’ should be inserted at the end of the main text and before the Acknowledgement section to indicate the contribution that each individual author has made to the manuscript.
Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
You will be asked to provide a conflict of interest statement during the submission process. See the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section for details on what to include in this section. Please ensure you liaise with all co-authors to confirm agreement with the final statement.
Abstract
Please provide an abstract of no more than 250 words containing the major keywords.
Keywords
Please provide up to 10 keywords, listed in order of importance.
Main text
• The journal uses British/US spelling, however authors may submit using either option as spelling of accepted papers is converted during the production process.
• Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
References
Submissions are not required to reflect the precise reference formatting of the journal (use of italics, bold etc.), however it is important that all key elements of each reference are included. Please see below for examples of reference content requirements.
References follow the Harvard style, i.e. the author, date system. In the text give the author’s name followed by the year in parentheses: Smith (2000). If several papers by the same authors and from the same year are cited, a,b,c etc should be inserted after the year of publication. In the reference list, references should be listed in alphabetical order. Reference to 'unpublished data' and 'data not shown' should be avoided; instead the data should be included in the Supporting Information.
Submissions are not required to reflect the precise reference formatting of the journal (use of italics, bold etc.), however it is important that all key elements of each reference are included. Please see below for examples of reference content requirements.
Reference examples follow:
Journal Article
Chan HT, Xiao Y, Weldon WC, Oberste SM, Chumakov K, Daniell H (2016) Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes. Plant Biotechnology Journal 14: 2190–2200.
Book
Singh BP (ed) (2013) Biofuel Crop Sustainability, 2nd edn. John Wiley & Sons, Ltd: Oxford, UK. doi: 10.1002/9781118635797
Chapter in a Book
Lu A, Diehn S, Cigan M (2014) Maize protein expression. In: Recent Advances in Gene Expression and Enabling Technologies in Crop Plants (Azhakanandam K, Silverstone A, Daniell H Davey MR, eds), pp 3–40. New York: Springer.
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images, and appear on separate pages at the end of the main document. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. No vertical rules should be used. Units should appear in parentheses in the column headings, not in the body of the table. Repeated words or numerals on successive lines should be written in full. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
On initial submission, in order to aid the review process, Tables should be submitted as a single PDF file. Authors will be required to resupply tables in an editable format (Word/Excel) in subsequent revisions or on acceptance.
Figure Legends
Figure legends should be included below each figure. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text, but should not contain excessive methodological detail. Each should begin with a short title for the figure. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Where figures have been embedded in the manuscript text file, please include the legend directly underneath each figure. When uploading figures separately as individual image files, the online system presents you with the opportunity to include the figure legend, meaning it will then be incorporated automatically underneath each figure when the PDF is generated for the reviewers.
All figures will be assessed for potential improper image manipulation as part of the review process.
Preparing Figures
Although we encourage authors to send us the highest-quality figures possible, for peer-review purposes we are happy to accept a wide variety of formats, sizes, and resolutions.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
With the exception of composite photographs suitable for full-page reproduction (maximum width, including lettering, 16.8 cm), all other figures will be typeset to a maximum width of 8 cm (including all lettering). Labelling on the figures should be in 8pt Helvetica if possible. Figure sections should be designated with lower case letters. Magnification bars should be given on electron and light microscope photographs. Error bars must be included on graphs, and the method used to derive the error bars included in the legend.
Colour figures: Figures submitted in colour will be reproduced in colour online free of charge.
Statistics
All statements concerning quantitative differences between experimental conditions should be based on quantitative data and adequate statistical treatment. Where relevant, blots should be scanned to obtain quantitative data. Statistics should be based on independent biological samples. The deviation parameter, the number of biological samples and the statistical procedures should be provided for each dataset either in the Experimental Procedures section or in the figure legends. Technical replicates should be averaged before statistical treatment and not used to calculate deviation parameters. In the case of multiple comparisons (e.g. microarray data), the probability of false positives should be considered in the analysis. Experimental procedures should be sufficiently detailed to enable the experiments to be reproduced.
Reporting of large-scale microarray and omics data
Reporting standards for large-scale omics datasets are constantly evolving and PBJ will follow common sense standards currently accepted in the field. PBJ currently adopts the microarray data guidelines developed by the Functional GEnomics Data Society (FGED) and requires that all authors using microarray data in their manuscript submit a complete data set to one of two databases prior to manuscripts submission: the National Centre for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) or the European Bioinformatics Institute (EMBL-EBI) ArrayExpress repository. The procedure is mandatory for all papers using microarray data. Authors including microarray analysis should refer to the MIAME recommendations (http://fged.org/projects/miame/ ) for guidance in preparing their manuscripts. Guidelines for the preparation of proteomics data can be found at http://www.psidev.info/miape/. For the current recommended practice on the preparation and reporting of metabolomics data, authors are referred to the publication by Fernie et al. (http://www.plantcell.org/content/23/7/2477.full).
Supporting Information
Supporting information is information that is not essential to the article but that provides greater depth and background. It is hosted online only, and appears without editing or typesetting. It may include datasets, tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information. Only material that is a valuable addition to the article should be included. Supporting Information will be reviewed.
Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
The availability of Supporting Information should be indicated in the main manuscript by a paragraph, to appear after the references at the end of the manuscript file, headed 'Supporting Information'. Legends should list the titles of all supporting figures, tables, data etc. In order to protect reviewer anonymity, material posted on authors’ websites cannot be reviewed.
Supporting Information items should be referred to in the text as follows:
Supporting figures: Figure S1, Figure S2 etc. Supporting tables: Table S1, Table S2 etc.
Supporting data: Data S1, Data S2 etc.
Supporting experimental procedures: Methods S1, Methods S2 etc.
Supporting animations: Movie S1, Movie S2 etc.
Any other text-based Supporting Information: Appendix S1, Appendix S2 etc.
The above order should be used when listing the Supporting Information legends, both in the short versions in the main manuscript text file, as well as in the separate full legends file.
On initial submission, in order to aid the review process, Supporting Tables should be submitted as a single PDF file, or as multiple PDF files in the event of multiple tabs within an original Excel file. Authors will be required to resupply Supporting Tables in an editable format (Word/Excel) in subsequent revisions or on acceptance.
General Style Points
The following links provide general advice on formatting and style.
• Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only. Acceptable abbreviations that do not need to be defined are listed here: http://www.blackwellpublishing.com/pdf/em1.pdf.
• Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
• Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8 mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
• Scientific, protein, gene and trade names: Complete scientific names should be given when organisms are first mentioned. The genus name may subsequently be abbreviated to the initial. It is important to differentiate between genes and proteins. All gene names and loci should be written in italic type; proteins should be upright. Chemical substances should be referred to by the generic name only. Trade names should be capitalized, and the manufacturer’s name and website given.
Wiley Author Resources
Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.
Editing, Translation and Formatting Support: Wiley Editing Services can greatly improve the chances of your manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting and figure preparation, Wiley Editing Services ensures that your manuscript is ready for submission.
4. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Editorial Review and Acceptance The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed.
Authors are given the option to select a preferred Associate editor to handle their manuscript though should note that Editors are allocated to manuscripts based upon various criteria including availability, workload and expertise, and preferred Associate editors cannot be guaranteed.
All submissions will be considered by the Editor-in-Chief and/or an Associate Editor to determine whether they fall within the scope of the journal and to ensure homogeneity in terms of scientific standards. Submissions that do will be sent out for full external review; those that do not will be returned to the submitting author quickly so that submission elsewhere will not be delayed. Manuscripts sent out for external review will typically be assessed by at least two experts; however, in extenuating circumstances (e.g. because of a delay caused by an overdue reviewer), the Associate Editor may make a recommendation based on the comments of only one reviewer, plus his/her own assessment of the manuscript.
Revisions and resubmissions of previously rejected manuscripts will typically be sent to the same reviewers who saw the original version, providing those reviewers are available. However, in some cases, the Associate Editor may decide that it is not appropriate to re-invite one or more of the original reviewers and/or may judge that a fresh reviewer is needed.
Revised manuscripts must be submitted within 1 month of authors being notified of ‘Minor revision’ decision. Revised manuscripts submitted after this time will be considered as completely new submissions, and be subject again to the full review procedure. This time limit will be rigidly adhered to except under unusual circumstances, which must be explained in full, in writing, to the Editor-in-Chief.
Resubmissions of previously rejected manuscripts will typically be sent to the same reviewers who saw the original version, providing those reviewers are available. However, in some cases, the Associate Editor may decide that it is not appropriate to re-invite one or more of the original reviewers and/or may judge that a fresh reviewer is needed. Resubmissions should be made within 1 year of the original decision as the impact of the work, and hence its suitability for publication in Plant Biotechnology Journal, may be lessened as knowledge advances.
Revised manuscripts must be in their final form when submitted, using red font to indicate the revised sections of the manuscript. Note that the files submitted should be in their final format for publication as the files accepted within the ScholarOne system will be the files which are supplied to the publisher. The proofs received later are for correction of typographical errors only. They should not be used for final changes to articles; such changes must be made to the manuscript before it goes to the publisher. Major alterations to the text at proof stage may be charged to the author and may delay publication.
Wiley's policy on confidentiality of the review process is available here.
Use of ‘unpublished’ or ‘not shown’ data
The statements ‘data not shown’ or ‘unpublished’ should be avoided; instead, the data should be included in the Supporting Information.
Species Names
Upon its first use in the title, abstract and text, the common name of a species should be followed by the scientific name (genus, species and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, the scientific name should be used only.
Genetic Nomenclature
Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see http://varnomen.hgvs.org/, where examples of acceptable nomenclature are provided.
Data storage and documentation
PBJ encourages data sharing wherever possible, unless this is prevented by ethical, privacy or confidentiality matters.
To faciliate data access, PBJ fully supports the use of preprint servers such as BioRXiv.
In general, the broad and systematic analysis of microarray datasets or RNA sequence datasets in papers published by PBJ must be accompanied by a complete dataset deposited in a publicly accessible repository. However, if the function of a specific gene or gene family is described that became first apparent in a microarray or RNA sequence experiment, and no further description of the analysis of the full dataset is provided in the manuscript, public deposition of the full dataset is not necessary for publication by PBJ.
For all data made publicly available authors should ensure that appropriate linking details and identifier(s) are included in the publication and where possible the repository, to facilitate linking between the journal article and the deposited data. If such a repository does not exist, data should be included as supporting information to the published paper or authors should agree to make their data available upon reasonable request.
If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Availability of biological and chemical material
Publication of a paper in PBJ explicitly requires that authors will provide, for non-profit research, all the biological and chemical materials not commercially available, including all plant cultivars, cell lines, DNA, antibodies and other similar materials, that are used for the experiments reported. Seeds of mutants described must be deposited at the appropriate stock centre and accession numbers provided. PBJ expects that all authors will conform to the National Science Advisory Board for Biosecurity (NSABB) guidelines for Dual Use Life Sciences Research.
To ensure complete transparency of this requirement, PBJ requires authors to state that these materials will be available on request. Requests must be reasonable with regard to the amount of material that can be provided and the sharing of costs, particularly when materials have required substantial effort for their production.
Registration of Nucleotide Sequence Data
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
GenBank http://www.ncbi.nlm.nih.gov
Papers containing amino acid sequences must supply a UniProt/Swiss-Prot accession number. To obtain an accession number, please use the UniProt/Swiss-Prot data submission tool (SPIN) at http://www.ebi.ac.uk/swissprot/Submissions/submissions.html.
Nucleotide and amino acid sequence accession numbers should be incorporated into manuscripts after the Material and Methods section. Any paper that does not have accession number(s) by proof stage will not be published until they have been provided.
Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to, employment with or funding from a commercial entity, patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission and include a statement in the Acknowledgements section. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships. Discovery of the failure to adequately disclose a conflict of interest at submission or during the review process may result in the rejection of a manuscript or other author sanctions.
Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/
Authorship
The list of authors should accurately illustrate who contributed to the work and how. A section entitled ‘Author Contributions’ should be added to the manuscript before the Acknowledgement section to indicate the contribution that each individual author has made to the manuscript.
1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
2. Been involved in drafting the manuscript or revising it critically for important intellectual content;
3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.
Additional authorship options
Joint first or senior authorship: In the case of joint first authorship a note should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’
ORCID
As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.
Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. By submitting your manuscript to this journal you accept that your manuscript may be screened for similarity against previously published works. Read our Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at https://authorservices.wiley.com/ethics-guidelines/index.html
PBJ is an Open Access journal: authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and identify as the original publisher.
Open Access Fees: Information on the Article Publication Charge for publishing in the journal is available here.
If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to login to Author Services, where via the Wiley Author Licensing Service (WALS), they will be able to complete the license agreement on behalf of all authors on the paper.
To find out which Created Commons Licenses are available for the journal, click here. To learn more about Creative Commons Licenses and to preview terms and conditions of the agreements, please click here. Note that certain funders mandate a particular type of CC license be used; to check this, please click here.
6. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted article received in production When your accepted article is received by Wiley’s production team, the corresponding author will receive an email asking him/her to login or register with Author Services. The corresponding author will then be asked to sign a publication license at this point.
Accepted Articles
The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, are given a Digital Object Identifier (DOI), which allows them to be cited and tracked, and are indexed by PubMed. After publication of the final version article (the article of record), the DOI remains valid and can continue to be used to cite and access the article.
Accepted Articles will be indexed by PubMed; submitting authors should therefore carefully check the names and affiliations of all authors provided in the cover page of the manuscript so it is correct for indexing. Subsequently the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.
Proofs
Once your paper is typeset you will receive an email notification of the URL from where to download a PDF typeset page proof, associated forms and full instructions on how to correct and return the file.
Please note that the authors are responsible for all statements made in the work, including changes made during the editorial process and thus authors must check the proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.
Early View
Once the proof is corrected the journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion into an issue. Note there may be a delay after corrections are received before your article appears online, as Editors may also need to review proofs. Once your article is published on Early View no further changes to your article are possible. Your Early View article is fully citable and carries an online publication date and retains the DOI assigned earlier at Accepted Articles stage.
Cover Images
Photographs of high quality suitable for the cover of PBJ are welcomed. They should be sent to the Editorial Office and be accompanied by a brief descriptive summary. It is preferred, but not essential, that these should be related to submitted papers.
Access and sharing
When your article is published online:
• You receive an email alert (if requested).
• You can share a link to your published article through social media.
• As the author, you will have free access to your paper (after accepting the Terms & Conditions of use, you can view your article).
• The corresponding author and co-authors can nominate colleagues to receive a publication alert and free online access to your article.
Now is the time to start promoting your article. Find out how to do that here.
Measuring the Impact of an Article
Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.
8. EDITORIAL OFFICE CONTACT DETAILS
Plant Biotechnology Journal Editorial Office
John Wiley & Sons, Inc
9600 Garsington Road
Oxford, OX4 2DQ,
UK
Editorial Office Staff
Jim Ruddock, Managing Editor
Email: plant-biotechj@wiley.com
Lauren Dawson, Editorial Assistant
Email: plant-biotechj@wiley.com
Author Guidelines updated November 2019
Tools
Plant Biotechnology Journal is published by Wiley-Blackwell in association with the Society for Experimental Biology (SEB) and the Association of Applied Biologists (AAB).
